Irish Life Investment Managers’s Nektar Therapeutics NKTR Stock Holding History

Irish Life Investment Managers’s Portfolio NKTR Stock Details NKTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$54.8K	Buy	+317	New	+$48.6K	﹤0.01%	1297

Other funds holding NKTR

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Irish Life Investment Managers's NKTR Position: Q2 2013 in Review

Irish Life Investment Managers opened a new position in Nektar Therapeutics (NKTR) in Q2 2013: 317 shares worth $54.8K. The stake represents ﹤0.01% of the portfolio and ranks #1297 among its holdings.

139 funds tracked by Wall St. Rank hold NKTR as of Q2 2013.

Irish Life Investment Managers held 317 shares of Nektar Therapeutics worth $54.8K as of Q2 2013.
Nektar Therapeutics was a new Irish Life Investment Managers position in Q2 2013.
Nektar Therapeutics made up ﹤0.01% of Irish Life Investment Managers's portfolio in Q2 2013, its #1297 holding.
139 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2013.

Based on Irish Life Investment Managers's 13F filing for Q2 2013, filed 13 Aug 2013.